SCHEDULE 13G Filed 2026-10-28 Event — SEC 0000070858-26-000540 →

→ CADIZ INC CDZI

Stake: — Shares: — Class: Common Stock

Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 20/100 · Filer 90d Win Rate: 33% · Hist. 90d Edge: +0.8%

Disqualifiers: ACTIVE_DILUTION_SHELF: Active 424B5 / S-3 shelf takedown within ±30d

Filer track record (4 filings): 33% 90d win rate, +0.8% 90d edge
Elevated short days-to-cover (9.0 DTC)
Short interest building (+24.9% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

3 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

135 filings by this filer

134 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 8.97

13,337,205 shares short · +24.9% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-09	Hernandez Jacinto J	officer	Award	800,000	—	—
2026-09-09	Hernandez Jacinto J	officer	Award	800,000	—	—
2026-04-08	Rivera Cathryn	officer	Award	10,000	—	—

Other 13D/G Filings on CADIZ INC

Filed	Form	Filer	Stake	Shares
2023-07-06	SC	Heerema International Group Services SA	—	—	view →
2019-02-07	SC	LC CAPITAL MASTER FUND LTD	—	—	view →
2018-05-03	SC	Water Asset Management LLC	—	—	view →

Other Filings by BANK OF AMERICA CORP /DE/

Filed	Form	Issuer	Stake	Shares
2026-10-28	SCHEDULE 13G	Q32 Bio Inc.	—	—	view →
2026-10-28	SCHEDULE 13G	USA TODAY Co., Inc.	—	—	view →
2026-10-28	SCHEDULE 13G	Liberty Live Holdings, Inc.	—	—	view →
2026-10-28	SCHEDULE 13G	Jasper Therapeutics, Inc.	—	—	view →
2026-10-28	SCHEDULE 13G	Dine Brands Global, Inc.	—	—	view →
2026-10-15	SCHEDULE 13D/A	Nuveen Minnesota Quality Municipal Income Fund	100.00%	478	view →
2026-10-07	SCHEDULE 13G	ACCENDRA HEALTH INC/VA/	—	—	view →
2026-10-05	SCHEDULE 13D/A	Nuveen Quality Municipal Income Fund	52.50%	7,495	view →
2026-10-02	SCHEDULE 13D/A	Nuveen Municipal Credit Opportunities Fund	50.70%	2,050	view →
2026-09-17	SCHEDULE 13D/A	PIMCO CALIFORNIA MUNICIPAL INCOME FUND	79.40%	1,920	view →
2026-08-26	SCHEDULE 13D/A	PIMCO NEW YORK MUNICIPAL INCOME FUND II	100.00%	760	view →
2026-08-26	SCHEDULE 13D/A	PIMCO MUNICIPAL INCOME FUND II	79.50%	3,860	view →
2026-08-03	SCHEDULE 13G	Total Return Securities Fund	—	—	view →
2026-08-03	SCHEDULE 13G	Fulcrum Therapeutics, Inc.	—	—	view →
2026-08-03	SCHEDULE 13G	CytomX Therapeutics, Inc.	—	—	view →
2026-08-03	SCHEDULE 13G	IREN Ltd	—	—	view →
2026-08-03	SCHEDULE 13G	Inhibrx Biosciences, Inc.	—	—	view →
2026-08-03	SCHEDULE 13G	BLACKROCK CREDIT ALLOCATION INCOME TRUST	—	—	view →
2026-08-03	SCHEDULE 13G	Research Alliance Corp III	—	—	view →
2026-08-03	SCHEDULE 13G	FRANKLIN STREET PROPERTIES CORP /MA/	—	—	view →

Showing 20 of 134

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →